Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsPreferred Shares RepurchasedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PharmaCyte Biotech (PMCB) Exchange Rate Effect (2016 - 2026)

PharmaCyte Biotech (PMCB) has disclosed Exchange Rate Effect for 12 consecutive years, with $2587.0 as the latest value for Q1 2026.

  • Quarterly Exchange Rate Effect rose 312.22% to $2587.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2946.0 through Jan 2026, up 308.49% year-over-year, with the annual reading at -$358.0 for FY2025, 29.53% up from the prior year.
  • Exchange Rate Effect for Q1 2026 was $2587.0 at PharmaCyte Biotech, up from -$381.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $3544.0 in Q2 2022, with the low at -$5276.0 in Q2 2023.
  • Average Exchange Rate Effect over 5 years is -$144.06, with a median of $61.0 recorded in 2024.
  • The sharpest move saw Exchange Rate Effect surged 459.87% in 2022, then crashed 1116.19% in 2023.
  • Over 5 years, Exchange Rate Effect stood at -$720.0 in 2022, then tumbled by 120.97% to -$1591.0 in 2023, then soared by 103.83% to $61.0 in 2024, then plummeted by 724.59% to -$381.0 in 2025, then surged by 779.0% to $2587.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $2587.0, -$381.0, and $123.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.